In another study on 108 NB cases, TERT rearrangements were detected in 23% of stage 3 and stage 4 cases, regardless of the amplification of MYCN (37%) or ATRX mutations (11%), and were confirmed as an independent prognostic factor [8]. This evidence concerns the gene ATRX and neuroblastoma.